Latest news
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Business WireBusiness Wire · Wed, 05 Aug 2026 12:00:00 GMTBioInvent International Publishes Preclinical Proof-Of-Concept Data Supporting Mechanistic Rationale For BI-1206 And BI-1607 In Combination With Immune Checkpoint Blockade - marketscreener.commarketscreener.com · Tue, 28 Jul 2026 09:21:13 GMTKazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 07:00:00 GMT